MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Study of prevalence of Axis-1 DSM-4 psychiatric disorders in patients with parkinsonism in a rural movement disorder clinic in Western India

    D. Desai, S. Singh, S. Desai (Anand, India)

    Objective: To assess the prevalence of Axis-1 DSM-4 [The Diagnostic and Statistical Manual of Mental disorders] psychiatric disorders in patients with Parkinson’s disease [PD], atypical…
  • 2019 International Congress

    Neuropsychiatric clusters in patients with Parkinson’s disease and their clinical and demographic correlates

    M. Sommerauer, C. Schedlich-Teufer, P. Reker, E. Kalbe, J. Kessler, M. Barbe (Köln, Germany)

    Objective: To assess clusters of neuropsychiatric symptoms in Parkinson’s disease and their relation to motor symptoms and demographic markers in a large PD cohort. Background:…
  • 2019 International Congress

    Management of Patients with Functional Movement Disorders: A Transcultural Perspective

    C. Maurer, D. Anderson, A. Asadi-Pooya, J. Baizabal, M. Damianova, C. Ganos, R. Kanaan, M. Tijssen, J. Kwasa, I. Moreno, S. Pandey, JE. Park, D. Saylor, M. Stamelou, C. Stephen, T. Teodoro, M. Tinazzi, K. Lafaver (Stony Brook, NY, USA)

    Objective: To compare the clinical management, available resources and barriers to care for patients with functional movement disorders (FMD) across 15 countries around the globe.…
  • 2019 International Congress

    Evaluating IL6 and mitochondrial DNA levels as a potential biomarker in carriers of Parkin and PINK1 mutations

    M. Borsche, I. König, S. Delcambre, S. Petrucci, A. Balck, T. Gasser, N. Brüggemann, S. Pereira, K. Badanjak, K. Brockmann, E M. Valente, R. Youle, A. Grünewald, C. Klein (Lübeck, Germany)

    Objective: To discriminate affected PARK-Parkin and PARK-PINK1 mutation carriers from idiopathic Parkinson’s disease (PD) patients and healthy controls using serum IL-6 and mtDNA levels. Background:…
  • 2019 International Congress

    Spastic Paraplegia Type 64: a Case Series

    KCD. Donis, LAP. Paskulin, RBT. Tenório, JWR. Rocha, TOS. Silva, JMS. Saute (Porto Alegre, Brazil)

    Objective: to present four cases (two families) with a likely diagnosis of spastic paraplegia type 64 (SPG 64), broadening this disease phenotype. Background: SPG64 is…
  • 2019 International Congress

    The PLA2G6 Gene Mutation Causes Parkinson’s Disease: A Case Report

    L. Kou, T. Wang, L. Liu, GX. Zhang (Wuhan, China)

    Objective: To investigate the clinical features of Parkinson's disease caused by PLA2G6 gene mutation. Background: Early-onset Parkinsonism is a group of syndromes characterized by Parkinson's disease…
  • 2019 International Congress

    Prevalence of Fabry disease among patients with Parkinson’s disease

    A. Mosejova, S. Oppermann, V. Han, P. Dosekova, J. Cobejova, M. Cobej, P. Levicka, S. Liesenerova, T. Lorincova, M. Ostrozovicova, D. Sendekova, V. Sukovska, Z. Gdovinova, P. Bauer, M. Skorvanek (Kosice, Slovakia)

    Objective: To determine the prevalence of Fabry disease (FD) among patients with Parkinson’s disease (PD). Background: Increased prevalence of PD disease has been previously reported…
  • 2019 International Congress

    Sleep Aspects on Video-Polysomnography in P.A53T SNCA Mutation Carriers

    AM. Simitsi, C. Koros, M. Stamelou, D. Papadimitrioy, A. Bougea, I. Pachi, N. Papagiannakis, R. Antonelou, E. Angelopoulou, K. Lourentzos, L. Stefanis, A. Bonakis (Athens, Greece)

    Objective: To determine whether REM sleep behavior disorder (RBD) and other sleep abnormalities occur in carriers of the p.A53T alpha-synuclein gene (SNCA) mutation, the prototypical…
  • 2019 International Congress

    Determining Outcome of Deep Brain Stimulation Surgery in Parkinson’s Disease Patients

    E. Yoon, S. Ahmed, S. Bandres-Ciga, S. Scholz, C. Lungu, D. Hernandez, A. Singleton, D. Ehrlich (Bethesda, MD, USA)

    Objective: To assess the role of monogenic forms of PD and polygenic risk scores (PRS) on the motor and cognitive outcome of deep brain stimulation…
  • 2019 International Congress

    Digenic inheritance of WARS2 and CHRNA6 mutations in infantile parkinsonism

    S. Galosi, S. Martinelli, V. Cordeddu, S. Fucile, C. Limatola, R. Carrozzo, M. Tartaglia, V. Leuzzi (Rome, Italy)

    Objective: To provide evidence of digenic inheritance in infantile parkinsonism. Background: Oligogenic inheritance has been demonstrated in PD[1],where patients with a primary genetic cause can…
  • « Previous Page
  • 1
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley